Nelson N, Jigo R, Clark G
Cancers (Basel). 2023; 15(16).
PMID: 37627161
PMC: 10452424.
DOI: 10.3390/cancers15164133.
Williams O, Hu L, Huang W, Patel P, Bartom E, Bei L
J Biol Chem. 2023; 299(7):104867.
PMID: 37247756
PMC: 10404618.
DOI: 10.1016/j.jbc.2023.104867.
Salla M, Guo J, Joshi H, Gordon M, Dooky H, Lai J
Int J Mol Sci. 2023; 24(6).
PMID: 36983040
PMC: 10055751.
DOI: 10.3390/ijms24065967.
Han Y, Zhang X, Guan M, Huo C, Yu C, Hu B
J Cell Mol Med. 2022; 26(12):3538-3547.
PMID: 35611809
PMC: 9189339.
DOI: 10.1111/jcmm.17395.
Hossain M, Roy A, Islam M
Sci Rep. 2020; 10(1):14542.
PMID: 32884013
PMC: 7471297.
DOI: 10.1038/s41598-020-71457-1.
NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.
Ko K, Jeong S, Lim J, Lee K, Lee M, Chi S
Oncogene. 2020; 39(34):5675-5689.
PMID: 32690868
DOI: 10.1038/s41388-020-01392-y.
Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.
Tripathi K, Garg M
J Cell Commun Signal. 2018; 12(3):513-527.
PMID: 29330773
PMC: 6039341.
DOI: 10.1007/s12079-017-0441-3.
Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
Ciribilli Y, Borlak J
Oncotarget. 2017; 8(60):101808-101831.
PMID: 29254206
PMC: 5731916.
DOI: 10.18632/oncotarget.21981.
The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T, Schmidt M, Donninger H, Clark G
Cancer Lett. 2017; 400:30-36.
PMID: 28455242
PMC: 5502528.
DOI: 10.1016/j.canlet.2017.04.030.
Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.
Arora P, Basu A, Schmidt M, Clark G, Donninger H, Nichols D
Hepatology. 2017; 65(5):1462-1477.
PMID: 28090674
PMC: 5397368.
DOI: 10.1002/hep.29049.
Ras signaling through RASSF proteins.
Donninger H, Schmidt M, Mezzanotte J, Barnoud T, Clark G
Semin Cell Dev Biol. 2016; 58:86-95.
PMID: 27288568
PMC: 5034565.
DOI: 10.1016/j.semcdb.2016.06.007.
NORE1A Regulates MDM2 Via β-TrCP.
Schmidt M, Calvisi D, Clark G
Cancers (Basel). 2016; 8(4).
PMID: 27023610
PMC: 4846848.
DOI: 10.3390/cancers8040039.
NORE1A induction by membrane-bound CD40L (mCD40L) contributes to CD40L-induced cell death and G1 growth arrest in p21-mediated mechanism.
Elmetwali T, Salman A, Palmer D
Cell Death Dis. 2016; 7:e2146.
PMID: 26986513
PMC: 4823953.
DOI: 10.1038/cddis.2016.52.
Ras Regulates Rb via NORE1A.
Barnoud T, Donninger H, Clark G
J Biol Chem. 2015; 291(6):3114-23.
PMID: 26677227
PMC: 4742771.
DOI: 10.1074/jbc.M115.697557.
RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion.
Han Y, Dong Q, Hao J, Fu L, Han X, Zheng X
Tumour Biol. 2015; 37(4):4865-71.
PMID: 26526576
DOI: 10.1007/s13277-015-4343-9.
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
Donninger H, Calvisi D, Barnoud T, Clark J, Schmidt M, Vos M
J Cell Biol. 2015; 208(6):777-89.
PMID: 25778922
PMC: 4362463.
DOI: 10.1083/jcb.201408087.
Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
Schmidt M, Donninger H, Clark G
J Biol Chem. 2014; 289(45):31102-10.
PMID: 25217643
PMC: 4223314.
DOI: 10.1074/jbc.M114.594283.
lgl Regulates the Hippo Pathway Independently of Fat/Dachs, Kibra/Expanded/Merlin and dRASSF/dSTRIPAK.
Parsons L, Grzeschik N, Richardson H
Cancers (Basel). 2014; 6(2):879-96.
PMID: 24743776
PMC: 4074808.
DOI: 10.3390/cancers6020879.
Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma.
Richter A, Haag T, Walesch S, Herrmann-Trost P, Marsch W, Kutzner H
Cancers (Basel). 2013; 5(4):1566-76.
PMID: 24252868
PMC: 3875954.
DOI: 10.3390/cancers5041566.
Ras and rheb signaling in survival and cell death.
Ehrkamp A, Herrmann C, Stoll R, Heumann R
Cancers (Basel). 2013; 5(2):639-61.
PMID: 24216995
PMC: 3730321.
DOI: 10.3390/cancers5020639.